Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 4,130.00
+45.00 (1.10%)
Apr 8, 2026, 3:30 PM KST
Yuyu Pharma Revenue
In the year 2025, Yuyu Pharma had annual revenue of 140.88B KRW with 5.81% growth. Yuyu Pharma had revenue of 34.34B in the quarter ending December 31, 2025, with 4.17% growth.
Revenue
140.88B
Revenue Growth
+5.81%
P/S Ratio
0.46
Revenue / Employee
554.66M
Employees
254
Market Cap
65.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 140.88B | 7.74B | 5.81% |
| Dec 31, 2024 | 133.15B | -4.06B | -2.96% |
| Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
| Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
| Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 657.61B |
| Ildong Holdings | 590.89B |
| HANDOK | 535.14B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| MYUNGMOON Pharm co.,Ltd | 195.25B |
| Kukje Pharma | 175.50B |
| CKD Bio | 159.93B |
| Hana Pharm | 139.33B |